NANOVIRICIDES, INC. Derivative Liability
NANOVIRICIDES, INC. (NNVC) had Derivative Liability of $1.15 million as of 2020-03-23, per its 10-K filed 2021-10-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2021-10-12
- 2020-03-23: Derivative Liability $1.15M.
- 2017-11-13: Derivative Liability $5.86M.
| Period end | Derivative Liability |
|---|---|
| 2020-03-23 | $1.15M 10-K · filed 2021-10-12 |
| 2017-11-13 | $5.86M 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |